Active Movers in Hot Line: Advanced Micro Devices (NASDAQ:AMD), McKesson (NYSE:MCK)

Advanced Micro Devices, Inc. (NASDAQ:AMD) [Trend Analysis] attempts to attain leading position in street, Shares price changes as it -4.31% to close at $11.55 with the total traded volume of 71.02 Million shares. At the annual SIGGRAPH conference back in July, AMD reported a quartet of pro-graphics cards featuring its Polaris GPU technology. One, the Radeon Pro SSG, was a proof of concept of sorts, which was outfitted with 1TB of solid state storage to aid with handling large datasets.

The other cards, the Radeon Pro WX 4100, WX 5100, and WX 7100, were a trio of new professional graphics products targeted at the mainstream workstation market.Like the consumer-targeted Radeon RX 480, RX 470, and RX 460, the Radeon Pro WX series of cards are built around AMD’s Polaris 10 and Polaris 11 GPUs. But, according to AMD, the Radeon Pro WX series are purpose build to address specific demands of the “modern content creation era”. The Radeon Pro WX 7100 GPU is the current top-of-the-line offering, that’s designed for engineering, media and entertainment workflows. The Radeon Pro WX 5100 GPU is targeted at product development, while the Radeon Pro WX 4100 GPU is meant for half-height designs, and targets CAD professionals with small form factor (SFF) workstations. The firm has institutional ownership of 70.80%, while insider ownership included 0.70%. Its price to sales ratio ended at 2.72. AMD attains analyst recommendation of 2.60 with week performance of 10.23%.

McKesson Corporation (NYSE:MCK) [Trend Analysis] try to make new thrust in street and making different trends, stocks trading ended with -0.38% to $141.53. McKesson Corporation (MCK) reported that it has completed the previously reported acquisition of Rexall Health for $2.9 billion CAD ($2.1 billion USD, or approximately $1.7 billion USD, net of certain estimated purchase price adjustments, proceeds from store divestitures, and tax benefits).

This follows the contract reached with the Competition Bureau of Canada for the acquisition of Rexall Health and approval received under the Investment Canada Act.As part of the transaction, McKesson has acquired approximately 470 retail pharmacies, and has agreed to divest stores in 26 local markets that the Competition Bureau of Canada identified during its review of the transaction. The share price of MCK attracts active investors, as stock price of week volatility recorded 1.56%. The stock is going forward to its 52-week low with 23.82% and lagging behind from its 52-week high price with -29.53%.

 

About Aaron Smithies

Aaron Smithies has a wide look on current monetary and financial events. He is an editor and a writer. His views; At Streetwise Report, we think the best opportunities arise from a complete understanding of all investing disciplines in order to identify the most attractive stocks at any given time. Interests: Biotech, Finical markets, Dividend stock ideas & income, Energy stocks, Consumer goods stocks

Leave a Reply

Your email address will not be published. Required fields are marked *